Infarmed has ordered the marketing suspension and withdrawal from the market of two cannabidiol creams whose use is prohibited in cosmetic products, the medicines authority said.
Information available on the Infarmed website explains that the decision was made based on a complaint received regarding Cannabiron CBD creams from Dietmed and Good Cannabis from Vitaceutics.
The National Drugs and Health Products Administration withdraws the 2022 circular on the use of cannabis and its derivatives in cosmetic products.
It is also explained that the creams in question contain cannabidiol, which is obtained through extracts or tinctures of hemp or its resin and is not allowed in cosmetic products.
“Organizations that have these products should not make them available,” and consumers who have these products “should not use them,” Infarmed recommends.
Author: Lusa
Source: CM Jornal
I’m Tifany Hawkins, a professional journalist with years of experience in news reporting. I currently work for a prominent news website and write articles for 24NewsReporters as an author. My primary focus is on economy-related stories, though I am also experienced in several other areas of journalism.